🇺🇸 FDA

Company profile · Sponsor

Eloxx

Eloxx Pharmaceuticals

ELOX · NYSE biotech ARLINGTON, MA, USA
Pipeline
7
Drugs
0
Patents
6

Quick answer

Eloxx (ELOX) is a biotech company. headquartered in ARLINGTON, MA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 6 patents to this profile..

Company facts

Ticker ELOX
Exchange NYSE
Company type biotech
Headquarters ARLINGTON, MA, USA
SEC CIK 0001035354

Pipeline (7)

Search pipeline →

  1. ELX-02

    Eloxx

    Cystic Fibrosis

    phase 2 small molecule completed

    2 trials

  2. ELX-02

    Eloxx

    Genetic Disease

    phase 2 small molecule terminated

    2 trials

  3. ELX-02

    Eloxx

    Alport Syndrome

    phase 2 small molecule completed

    1 trial

  4. Exaluren

    Eloxx

    Alport Syndrome, X-Linked

    phase 2 small molecule active

    1 trial

  5. ELX-02

    Eloxx

    Genetic Diseases

    phase 1 small molecule terminated

    1 trial

  6. ELX-02

    Eloxx

    Impaired Renal Function

    phase 1 small molecule completed

    1 trial

  7. Placebo

    Eloxx

    Genetic Disease

    phase 1 small molecule completed

    1 trial

Patents (6)

Search patents →

  1. US 11786539

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11613551

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11306115

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10899785

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10786520

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10576095

    Use of aminoglycoside analogs in the treatment of Rett syndrome

    Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Eloxx?

Eloxx (ELOX) is a biotech company. headquartered in ARLINGTON, MA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 6 patents to this profile..

What pipeline programs does Eloxx sponsor?

We track 7 ClinicalTrials.gov-linked programs for Eloxx, including ELX-02 and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Eloxx company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.